Filing Details

Accession Number:
0001209191-16-105765
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-03 19:09:27
Reporting Period:
2016-03-01
Filing Date:
2016-03-03
Accepted Time:
2016-03-03 19:09:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1182657 Md H Frank Valone C/O Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-01 6,528 $3.93 115,133 No 4 M Direct
Common Stock Acquisiton 2016-03-01 2,508 $2.90 117,641 No 4 M Direct
Common Stock Acquisiton 2016-03-01 1,714 $3.50 119,355 No 4 M Direct
Common Stock Disposition 2016-03-01 7,260 $16.47 112,095 No 4 S Direct
Common Stock Disposition 2016-03-01 3,490 $17.61 108,605 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-03-01 6,528 $0.00 6,528 $3.93
Common Stock Stock Option (Right to Buy) Disposition 2016-03-01 2,508 $0.00 2,508 $2.90
Common Stock Stock Option (Right to Buy) Disposition 2016-03-01 1,714 $0.00 1,714 $3.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,472 2019-08-11 No 4 M Direct
5,000 2020-06-09 No 4 M Direct
30,028 2021-06-07 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,000 Indirect By Trust
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. The shares were sold at prices between $16.02 and $17.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices between $17.02 and $17.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Fully vested.